Quaker Chemical CORP Form 4 insider transactions

Kristin Rokosky, SVP and CHRO of Quaker Chemical Corp, increased her direct beneficial ownership of common stock following RSU vesting and tax-related sales.

A Quaker Chemical Corp. executive converted restricted stock units and dividend equivalent rights into common stock, subsequently selling shares for tax withholding.

Andre Frodl, VP of R&D-Metals & Metalworking at Quaker Chemical Corp, reported the acquisition of 178 common shares and the disposition of 85 shares for tax purposes following RSU vesting.

QH Hungary Holdings, a 10% owner of Quaker Chemical Corp, amended existing and entered into new variable prepaid forward sale contracts, adjusting its beneficial ownership and share delivery obligations.

Gulf Hungary Holding Korlatolt Felelossegu Tarsasag, a 10% owner of Quaker Chemical Corp, amended existing and entered into new variable prepaid forward sale contracts involving 343,500 shares.

Quaker Chemical Corp. granted 913 restricted stock units to SVP and CTO Christine Procopio Johnson, vesting in three annual installments starting March 15, 2026.

Andre Frodl, VP of R&D-Metals & Metalworking at Quaker Chemical Corp, was granted 61 restricted stock units, aligning his interests with shareholders.

Anna Ransley, SVP and CDIO of Quaker Chemical Corp, reported a future disposition of 372 shares of common stock to cover tax obligations upon restricted stock vesting.

Quaker Chemical Corp. Director Fay West reported the vesting and conversion of 716 restricted stock units and 9 dividend equivalent rights into common stock, alongside a new grant of 1,198 restricted stock units as part of her 2025 compensation.

Quaker Chemical Corp. Director Russell Shaller reported significant changes in his beneficial ownership, converting restricted stock units and dividend equivalent rights into common stock, and receiving additional shares as part of his annual retainer.

Quaker Chemical Corp. Director William H. Osborne has reported the vesting of restricted stock units and dividend equivalent rights, along with the grant of new time-based restricted stock units as part of his 2025 compensation.

Quaker Chemical Corporation Director Sanjay Hinduja reported the conversion of restricted stock units and dividend equivalent rights into common stock, alongside the grant of new time-based restricted stock units as part of his 2025 compensation.

Quaker Chemical Corp. Director Charlotte C. Henry reported the vesting of 716 restricted stock units and related dividend equivalent rights, converting them into common stock, and the grant of 1,198 new restricted stock units as part of her 2025 compensation.

Quaker Chemical Corp. Director Jeffry D. Frisby reported the vesting of restricted stock units and dividend equivalent rights, along with the grant of new time-based restricted stock units as part of his 2025 compensation.

A director at Quaker Chemical Corp. (KWR) has filed a Form 4 detailing the vesting of restricted stock units, settlement of dividend equivalent rights, acquisition of shares as compensation, and a new grant of restricted stock units.

Quaker Chemical Corp. Director Mark Douglas reported the conversion of restricted stock units and dividend equivalent rights into common stock, alongside a new grant of restricted stock units as part of his 2025 compensation.

Quaker Chemical Corp. Director Michael F. Barry has reported the conversion of restricted stock units and dividend equivalent rights into common stock, alongside a new grant of 1,198 restricted stock units as part of his 2025 compensation.

Quaker Chemical Corp. Director Nandita Bakhshi reported an increase in her beneficial ownership of KWR common stock through the vesting of restricted stock units and the receipt of shares as part of her annual retainer.

Gulf Hungary Holding, a 10% owner of Quaker Chemical Corp (KWR), has amended a variable prepaid forward sale contract covering up to 350,000 shares, involving a payment of nearly $4.83 million to Citibank.

QH Hungary Holdings Ltd., a 10% owner and director of Quaker Chemical Corp., has amended an existing variable prepaid forward sale contract with Citibank, involving up to 350,000 shares and a payment of $4.83 million.

CEO Joseph A. Berquist purchased 482 shares of Quaker Chemical Corp stock at an average price of $103.6187 on May 9, 2025.

Robert T. Traub, SVP, GC & Corp. Sec. of Quaker Chemical Corp, reports transactions involving common stock and restricted stock units, including vesting and tax obligation fulfillment.

David Slinkman, SVP Chief Technology Officer of Quaker Chemical Corp, reports transactions involving common stock and restricted stock units.

Kristin Rokosky, SVP, CHRO of Quaker Chemical Corp, reports transactions involving common stock and restricted stock units, including acquisitions, disposals, and vesting.

Anna Ransley, SVP, CDIO of Quaker Chemical Corp, reports transactions involving common stock and restricted stock units, including acquisitions, disposals, and vesting.

Miguel Moreno Hernandez, SVP at Quaker Chemical Corp, reports transactions involving restricted stock units and common stock.

Ma Jun, SVP, Reg Comm Lead-APAC at Quaker Chemical Corp, reports transactions involving common stock and restricted stock units.

Jeffrey Kutz, VP and Chief Accounting Officer of Quaker Chemical Corp, reports the vesting and disposal of restricted stock units to cover tax obligations.

Jeffrey L. Fleck, SVP and Chief GSCO of Quaker Chemical Corp, reports transactions involving common stock and restricted stock units.

EVP and CFO Thomas Coler reports the vesting of restricted stock units and associated transactions.